NPI: 1619980430 · CLEVELAND, OH 44106 · Clinical Medical Laboratory · NPI assigned 08/14/2006
Authorized official SCHILLERO, ANTHONY controls 20+ related entities in our dataset. Read more
| Authorized Official | SCHILLERO, ANTHONY (DIRECTOR, FP&A) |
| NPI Enumeration Date | 08/14/2006 |
Other providers sharing the same authorized official: SCHILLERO, ANTHONY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 360,567 | $4.14M |
| 2019 | 387,073 | $4.15M |
| 2020 | 383,589 | $4.76M |
| 2021 | 508,649 | $7.26M |
| 2022 | 589,857 | $8.04M |
| 2023 | 728,465 | $7.04M |
| 2024 | 652,803 | $5.67M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 81,620 | 78,816 | $3.49M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 96,075 | 91,972 | $2.50M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 92,313 | 88,253 | $2.45M |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 12,728 | 12,390 | $1.67M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 42,536 | 35,925 | $1.62M |
| 84443 | Thyroid stimulating hormone (TSH) | 147,730 | 140,318 | $1.49M |
| 80053 | Comprehensive metabolic panel | 206,758 | 192,064 | $1.45M |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 54,871 | 52,204 | $1.37M |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 93,319 | 88,876 | $1.37M |
| 80061 | Lipid panel | 129,775 | 124,076 | $1.10M |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 50,252 | 47,757 | $888K |
| 36415 | Collection of venous blood by venipuncture | 321,579 | 285,618 | $830K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 162,254 | 145,260 | $822K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 5,370 | 4,995 | $673K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 12,597 | 11,551 | $635K |
| 85027 | 144,531 | 131,609 | $629K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 107,094 | 102,249 | $625K |
| 86003 | 51,975 | 8,599 | $603K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 25,611 | 24,513 | $548K |
| 86235 | 25,313 | 6,370 | $538K | |
| 86780 | 49,391 | 46,349 | $482K | |
| 86481 | 8,268 | 7,678 | $482K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 82,085 | 76,886 | $462K |
| 82607 | 45,533 | 43,141 | $451K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 7,923 | 7,720 | $419K |
| 88185 | 6,161 | 4,498 | $376K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 19,666 | 19,002 | $367K |
| 87506 | 2,553 | 2,378 | $351K | |
| 86803 | 34,949 | 33,078 | $341K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 10,705 | 8,910 | $340K |
| 82728 | 38,407 | 36,146 | $336K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 13,915 | 13,445 | $335K |
| 83655 | 32,140 | 31,272 | $315K | |
| 87800 | 8,910 | 8,402 | $268K | |
| 83970 | 10,995 | 10,289 | $256K | |
| 84439 | 44,190 | 41,516 | $247K | |
| 87340 | 33,836 | 32,252 | $243K | |
| 83550 | 36,499 | 34,413 | $200K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 35,956 | 32,761 | $193K |
| 82746 | 19,525 | 18,454 | $193K | |
| 86317 | 9,547 | 4,556 | $184K | |
| 87536 | 3,454 | 3,217 | $179K | |
| 81229 | 335 | 313 | $162K | |
| 87634 | 4,048 | 3,943 | $157K | |
| 84403 | 8,984 | 8,508 | $157K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2,406 | 2,361 | $157K |
| 83540 | 37,393 | 35,279 | $154K | |
| 80069 | 35,194 | 26,017 | $153K | |
| 83021 | 11,378 | 10,798 | $152K | |
| 87077 | 24,311 | 23,041 | $150K | |
| 86762 | 13,580 | 12,959 | $148K | |
| 84153 | 13,143 | 12,497 | $146K | |
| 87081 | 28,063 | 27,119 | $143K | |
| 80346 | 10,008 | 9,376 | $142K | |
| 87186 | 23,700 | 20,368 | $134K | |
| 86850 | 21,457 | 20,148 | $132K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 1,290 | 1,238 | $129K |
| 84402 | 6,974 | 6,704 | $124K | |
| 84702 | 12,259 | 9,870 | $123K | |
| 80361 | 10,071 | 9,454 | $123K | |
| 87522 | Neg quan hep c or qual rna | 4,303 | 3,994 | $114K |
| 87529 | 2,875 | 2,582 | $113K | |
| 86140 | 31,190 | 28,237 | $111K | |
| 86038 | 13,184 | 12,284 | $108K | |
| 88184 | 4,973 | 4,490 | $106K | |
| 83880 | 4,676 | 4,405 | $104K | |
| 82570 | 36,031 | 33,019 | $102K | |
| 84146 | 7,369 | 7,018 | $101K | |
| 83735 | 29,878 | 21,086 | $101K | |
| 83001 | 8,254 | 7,876 | $100K | |
| 83516 | 11,010 | 7,017 | $96K | |
| 83002 | 6,886 | 6,524 | $91K | |
| 80197 | 18,369 | 9,345 | $91K | |
| 82670 | 4,541 | 4,201 | $88K | |
| 80050 | General health panel | 6,278 | 5,862 | $88K |
| 82785 | 7,534 | 6,880 | $87K | |
| 87205 | 26,896 | 25,589 | $82K | |
| 83718 | 13,935 | 13,533 | $81K | |
| 84481 | 6,751 | 6,351 | $78K | |
| 83013 | 1,707 | 1,632 | $77K | |
| 80076 | 14,718 | 12,889 | $77K | |
| 82784 | 7,339 | 5,589 | $74K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 4,400 | 4,229 | $74K |
| 82043 | 19,388 | 18,473 | $71K | |
| 86665 | 4,647 | 3,636 | $70K | |
| 87799 | 6,279 | 3,572 | $67K | |
| 86160 | 7,009 | 4,608 | $67K | |
| 82627 | 4,187 | 3,980 | $67K | |
| 84445 | 1,774 | 1,684 | $63K | |
| 87902 | 321 | 314 | $63K | |
| 86225 | 7,342 | 6,684 | $63K | |
| 80074 | 3,689 | 3,496 | $62K | |
| 87070 | 9,998 | 9,434 | $62K | |
| 86706 | 9,175 | 8,409 | $60K | |
| 87497 | 4,081 | 2,594 | $57K | |
| 85652 | 30,746 | 28,508 | $57K | |
| 81001 | 27,644 | 25,705 | $57K | |
| 87075 | 7,509 | 7,011 | $49K | |
| 82024 | 1,972 | 1,777 | $48K | |
| 86376 | 4,831 | 4,543 | $48K | |
| 86900 | 22,437 | 20,926 | $48K | |
| 86901 | 22,389 | 20,880 | $47K | |
| 82533 | 4,307 | 3,866 | $47K | |
| 82465 | 14,415 | 13,996 | $46K | |
| 84425 | 3,189 | 2,986 | $44K | |
| 85045 | 14,112 | 13,485 | $44K | |
| 86147 | 1,060 | 907 | $44K | |
| 82652 | 2,255 | 2,072 | $43K | |
| 87631 | 524 | 505 | $42K | |
| 84550 | 13,626 | 12,620 | $41K | |
| 84480 | 4,154 | 3,927 | $41K | |
| 82950 | 11,132 | 10,371 | $40K | |
| 83498 | 2,045 | 1,957 | $40K | |
| 81025 | 6,435 | 6,135 | $39K | |
| 88342 | 883 | 756 | $38K | |
| 85610 | 17,714 | 15,654 | $38K | |
| 86787 | 4,462 | 4,049 | $37K | |
| 86832 | 306 | 289 | $37K | |
| 86664 | 3,809 | 3,447 | $36K | |
| 86696 | 2,707 | 2,572 | $36K | |
| 86704 | 5,216 | 4,706 | $35K | |
| 86833 | 297 | 282 | $34K | |
| 83525 | 4,149 | 3,895 | $34K | |
| 83690 | 7,299 | 6,770 | $34K | |
| 83993 | 2,385 | 2,257 | $34K | |
| 86431 | 8,832 | 8,306 | $34K | |
| 86200 | 3,874 | 3,632 | $33K | |
| 84156 | 15,019 | 13,230 | $33K | |
| 81003 | 21,616 | 20,546 | $33K | |
| 86663 | 3,816 | 3,455 | $32K | |
| 84460 | 9,626 | 8,875 | $32K | |
| 86146 | 874 | 741 | $32K | |
| 82248 | 9,692 | 8,443 | $31K | |
| 86480 | 572 | 561 | $31K | |
| 82105 | 3,162 | 2,963 | $31K | |
| 86800 | 2,982 | 2,530 | $31K | |
| 84450 | 8,378 | 7,756 | $30K | |
| 87102 | 4,655 | 4,485 | $30K | |
| 86364 | 3,325 | 2,727 | $29K | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 1,376 | 1,291 | $29K |
| 81381 | 389 | 354 | $28K | |
| 86765 | 2,983 | 2,793 | $28K | |
| 80348 | 3,798 | 3,435 | $27K | |
| 86735 | 2,798 | 2,624 | $27K | |
| 86334 | 2,020 | 1,826 | $25K | |
| 82977 | 5,420 | 4,206 | $25K | |
| 80324 | 4,191 | 3,856 | $25K | |
| 84305 | 1,605 | 1,538 | $25K | |
| 86695 | 2,712 | 2,572 | $25K | |
| 88142 | 1,740 | 1,697 | $25K | |
| 82550 | 5,667 | 5,184 | $25K | |
| 84681 | 2,246 | 2,005 | $25K | |
| 86039 | 3,157 | 2,916 | $24K | |
| 82247 | 7,562 | 5,901 | $24K | |
| 87493 | 1,587 | 1,450 | $24K | |
| 83615 | 5,647 | 4,917 | $23K | |
| 82565 | 6,644 | 6,093 | $23K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 70 | 67 | $22K |
| 82150 | 5,159 | 4,669 | $22K | |
| 86790 | 1,834 | 1,792 | $22K | |
| 83520 | 1,434 | 1,215 | $22K | |
| 85730 | 8,501 | 7,693 | $22K | |
| 86769 | 580 | 572 | $21K | |
| 80365 | 4,500 | 4,206 | $21K | |
| 80354 | 4,199 | 3,951 | $20K | |
| 84100 | 7,237 | 5,502 | $20K | |
| 80373 | 4,075 | 3,857 | $20K | |
| 86008 | 1,775 | 787 | $20K | |
| 84165 | 3,142 | 2,856 | $20K | |
| 80349 | 3,378 | 3,051 | $19K | |
| 84630 | 2,403 | 2,273 | $18K | |
| 87328 | 1,942 | 1,789 | $18K | |
| 82947 | 7,265 | 6,798 | $18K | |
| 84207 | 1,023 | 952 | $18K | |
| 86258 | 1,664 | 1,206 | $17K | |
| 84144 | 1,215 | 1,033 | $17K | |
| 86255 | 1,685 | 1,066 | $16K | |
| 82525 | 2,038 | 1,891 | $16K | |
| 87209 | 1,237 | 1,176 | $16K | |
| 86708 | 2,084 | 1,935 | $16K | |
| 87632 | 137 | 129 | $15K | |
| 80358 | 3,572 | 3,365 | $15K | |
| 80368 | 3,543 | 3,340 | $15K | |
| 82397 | 1,312 | 1,216 | $15K | |
| 86141 | 1,621 | 1,540 | $15K | |
| 84590 | 1,696 | 1,613 | $13K | |
| 84432 | 1,265 | 1,093 | $13K | |
| 84075 | 3,980 | 3,559 | $13K | |
| 80164 | 1,550 | 1,381 | $13K | |
| 82951 | 1,728 | 1,658 | $12K | |
| 83519 | 1,045 | 848 | $12K | |
| 84436 | 2,970 | 2,819 | $12K | |
| 83721 | 2,791 | 2,610 | $11K | |
| 85018 | 6,474 | 6,223 | $11K | |
| 84154 | 996 | 951 | $11K | |
| 87329 | 2,001 | 1,821 | $11K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 561 | 459 | $11K |
| 86870 | 560 | 489 | $11K | |
| 86644 | 1,522 | 1,277 | $11K | |
| 85014 | 5,533 | 5,329 | $10K | |
| 87450 | 1,110 | 1,072 | $10K | |
| 84520 | 3,577 | 3,320 | $9K | |
| 87177 | 1,367 | 1,240 | $9K | |
| 88112 | 400 | 369 | $9K | |
| 82140 | 1,005 | 897 | $8K | |
| 80177 | 992 | 921 | $8K | |
| 82378 | 837 | 758 | $8K | |
| 86592 | 2,650 | 2,417 | $8K | |
| 84155 | 3,754 | 3,325 | $8K | |
| 87467 | 1,496 | 1,198 | $8K | |
| 83921 | 606 | 568 | $8K | |
| 86381 | 520 | 486 | $7K | |
| 82103 | 957 | 774 | $7K | |
| 80353 | 796 | 709 | $7K | |
| 86618 | 656 | 589 | $7K | |
| 86694 | 636 | 576 | $7K | |
| 82390 | 971 | 905 | $7K | |
| 82653 | 467 | 441 | $6K | |
| 85379 | 1,013 | 943 | $6K | |
| 83020 | 662 | 615 | $6K | |
| 87210 | 2,098 | 2,005 | $6K | |
| 86645 | 488 | 449 | $6K | |
| 82330 | 820 | 723 | $5K | |
| 87505 | 173 | 165 | $5K | |
| 83883 | 462 | 423 | $5K | |
| 85613 | 763 | 647 | $5K | |
| 82610 | 384 | 376 | $5K | |
| 87206 | 1,323 | 1,005 | $5K | |
| 83521 | 668 | 578 | $5K | |
| 80345 | 498 | 435 | $5K | |
| 86705 | 661 | 607 | $5K | |
| 84484 | 615 | 562 | $5K | |
| 86015 | 696 | 640 | $5K | |
| 83010 | 520 | 426 | $4K | |
| 82952 | 1,789 | 1,722 | $4K | |
| 84270 | 278 | 271 | $4K | |
| 84478 | 1,144 | 766 | $4K | |
| 86256 | 448 | 403 | $4K | |
| 82157 | 182 | 174 | $4K | |
| 36416 | 1,172 | 1,078 | $4K | |
| 86341 | 244 | 164 | $3K | |
| 87449 | 418 | 391 | $3K | |
| 82672 | 228 | 216 | $3K | |
| 86036 | 436 | 368 | $3K | |
| 84479 | 853 | 811 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 131 | 130 | $3K |
| 84446 | 381 | 355 | $3K | |
| 87517 | 127 | 119 | $3K | |
| 86162 | 251 | 210 | $3K | |
| 84466 | 415 | 392 | $3K | |
| 82088 | 122 | 111 | $3K | |
| 80158 | 483 | 268 | $3K | |
| 87015 | 653 | 604 | $3K | |
| 80323 | 857 | 689 | $3K | |
| 85007 | 1,431 | 1,078 | $3K | |
| 87040 | 447 | 352 | $3K | |
| 86812 | 169 | 164 | $3K | |
| 86308 | 703 | 671 | $3K | |
| 80178 | 690 | 639 | $3K | |
| 87521 | Neg quan hep c or qual rna | 123 | 119 | $2K |
| 83090 | 263 | 248 | $2K | |
| 82657 | 112 | 96 | $2K | |
| 81243 | 113 | 99 | $2K | |
| 87084 | 460 | 229 | $2K | |
| 88304 | 115 | 95 | $2K | |
| 82542 | 151 | 133 | $2K | |
| 85246 | 132 | 109 | $2K | |
| 87109 | 199 | 186 | $2K | |
| 82274 | 172 | 170 | $2K | |
| 86318 | 285 | 270 | $2K | |
| 84134 | 227 | 185 | $2K | |
| 82379 | 135 | 134 | $2K | |
| 86593 | 675 | 614 | $2K | |
| 84166 | 227 | 170 | $2K | |
| 82164 | 201 | 180 | $2K | |
| 81509 | 46 | 46 | $2K | |
| 82310 | 535 | 500 | $2K | |
| 82017 | 118 | 117 | $2K | |
| 86001 | 184 | 61 | $2K | |
| 86301 | 170 | 155 | $2K | |
| 84244 | 122 | 111 | $2K | |
| 88341 | 91 | 14 | $2K | |
| 87184 | 255 | 229 | $2K | |
| 86880 | 411 | 358 | $2K | |
| 82787 | 86 | 69 | $1K | |
| 80175 | 165 | 153 | $1K | |
| 86304 | 127 | 112 | $1K | |
| 82104 | 152 | 147 | $1K | |
| 84132 | 484 | 384 | $1K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 27 | 27 | $1K |
| 87900 | 12 | 12 | $1K | |
| 82626 | 73 | 67 | $1K | |
| 80047 | 159 | 138 | $1K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 28 | 28 | $1K |
| 87106 | 116 | 116 | $994.01 | |
| 82139 | 63 | 60 | $937.06 | |
| 87476 | 42 | 39 | $905.77 | |
| 86774 | 82 | 74 | $839.29 | |
| 84703 | 155 | 152 | $818.82 | |
| 83835 | 72 | 65 | $811.82 | |
| 87185 | 319 | 226 | $741.81 | |
| 80202 | 96 | 43 | $711.88 | |
| 82040 | 300 | 272 | $682.08 | |
| 84080 | 70 | 65 | $639.56 | |
| 83605 | 82 | 72 | $611.67 | |
| 82085 | 96 | 92 | $594.25 | |
| 82172 | 47 | 44 | $537.58 | |
| 86825 | 16 | 15 | $492.72 | |
| 86335 | 31 | 26 | $468.45 | |
| 81050 | 225 | 157 | $449.48 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 2,056 | 1,955 | $371.61 |
| 84300 | 118 | 106 | $351.88 | |
| 82270 | 112 | 104 | $345.90 | |
| 87116 | 43 | 37 | $342.43 | |
| 82340 | 88 | 81 | $340.92 | |
| 87653 | 13 | 12 | $319.53 | |
| 83529 | 31 | 30 | $314.78 | |
| 83935 | 78 | 72 | $310.22 | |
| 80162 | 26 | 25 | $276.00 | |
| 85660 | 55 | 54 | $222.50 | |
| 88280 | 13 | 12 | $211.72 | |
| 80235 | 13 | 12 | $205.74 | |
| 82530 | 17 | 15 | $193.52 | |
| 86707 | 26 | 25 | $190.17 | |
| 82747 | 15 | 13 | $176.15 | |
| 86709 | 28 | 26 | $163.98 | |
| 80183 | 18 | 12 | $161.34 | |
| 86060 | 29 | 28 | $153.92 | |
| 87181 | 25 | 24 | $136.39 | |
| 82365 | 12 | 12 | $135.08 | |
| 82384 | 12 | 12 | $133.15 | |
| 80360 | 14 | 14 | $106.95 | |
| 80156 | 12 | 12 | $100.25 | |
| 85384 | 12 | 12 | $88.35 | |
| 80051 | 15 | 15 | $86.02 | |
| G0476 | Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test | 209 | 201 | $68.78 |
| 89055 | 15 | 15 | $66.00 | |
| 89125 | 12 | 12 | $53.75 | |
| 82438 | 12 | 12 | $49.24 | |
| 89050 | 14 | 12 | $40.46 | |
| 84133 | 12 | 12 | $39.48 | |
| 84157 | 14 | 12 | $34.98 | |
| 89051 | 12 | 12 | $34.48 | |
| 82945 | 14 | 12 | $33.82 | |
| 0753T | 522 | 267 | $0.00 | |
| 80321 | 128 | 106 | $0.00 | |
| 81490 | 12 | 12 | $0.00 | |
| 80372 | 17 | 17 | $0.00 | |
| 0064U | 28 | 28 | $0.00 |